I thought it a bit weird they didn't give out any hard numbers but JQ pointed out this isn't the first time (and not necessarily indicative of something negative). It still weird we don't even know which dose(s) and which patients were not in analysis. Martin Auster specifically asked about which dose(s) met primary endpoint and they didn't say.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.